Faes Farma (HAM:FFEA) ROCE %: 5.93% (As of Dec. 2025)


HAM:FFEA Faes Farma SA HAM:FFEA
93 GF Score
Price €4.59
GF Value €5.02
! 6 Warning Signs
View Full Analysis

What is Faes Farma ROCE %?

Faes Farma HAM:FFEA +0.99% 93 ROCE % is 5.93% as of Dec. 2025. GuruFocus rates HAM:FFEA with a GF Score™ of 93/100 and a GF Value™ of €5.02. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Faes Farma's annualized ROCE % for the quarter that ended in Dec. 2025 was 5.93%.

Faes Farma  (HAM:FFEA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Faes Farma ROCE % Related Terms

Faes Farma ROCE % Historical Data

* Premium members only.

The historical data trend for Faes Farma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Faes Farma ROCE % Chart

Faes Farma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.54 16.97 15.62 15.01 9.57

Faes Farma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.33 19.75 10.65 15.85 5.93
HAM:FFEA
93GF Score
Faes Farma SA HAM:FFEA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Faes Farma ROCE % Calculation

Faes Farma's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=91.273/( ( (853.082 - 103.455) + (1341.895 - 184.877) )/ 2 )
=91.273/( (749.627+1157.018)/ 2 )
=91.273/953.3225
=9.57 %

Faes Farma's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=58.494/( ( (1000.131 - 184.269) + (1341.895 - 184.877) )/ 2 )
=58.494/( ( 815.862 + 1157.018 )/ 2 )
=58.494/986.44
=5.93 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.93% mean?
Faes Farma (HAM:FFEA) has a ROCE % of 5.93% as of Dec. 2025.
Is Faes Farma's ROCE % too high?
Faes Farma's current ROCE % is 5.93%. The Drug Manufacturers industry median ROCE % is 7.01. Faes Farma's value of 5.93% is 15.4% below this industry median. Overall, Faes Farma has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's ROCE % compare to ZTS and UTHR?
Faes Farma's ROCE % of 5.93% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.01. Faes Farma's value of 5.93% is 15.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.01, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Faes Farma's current ROCE % of 5.93% is 15.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Faes Farma's current ROCE % is 5.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Faes Farma (HAM:FFEA) has a current ROCE % of 5.93%. The stock's GF Value™ is €5.02, compared to a current price of €4.59 — trading 8.7% below its estimated fair value. The current ROCE % is 5.93% and 15.4% below the Drug Manufacturers industry median of 7.01. Faes Farma's overall GF Score™ is 93/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Faes Farma (HAM:FFEA), the current ROCE % is 5.93% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Faes Farma (HAM:FFEA) Overvalued in 2026?

Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued. The current stock price of €4.59 is trading 8.7% below its estimated GF Value™ of €5.02.

Key valuation signals for HAM:FFEA:

  • ROCE %: 5.93%
  • GF Value™: €5.02 vs. price of €4.59 (8.7% below fair value)
  • GF Score™: 93/100 with 6 warning signs
  • Industry Position: 15.4% below the Drug Manufacturers median

No single metric tells the full story. See the HAM:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Faes Farma Business Description

Address Avenida Autonomia, 10, Leioa, Vizcaya, ESP, 48940
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
93GF Score

Get the complete analysis for HAM:FFEA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.59
Price
€5.02
GF Value